(n.d.-f)
Retatrutide's Phase 2 trial data (Jastreboff et al., NEJM 2023) identified a side-effect profile broadly consistent with other incretin-based therapies: Gastrointestinal : Nausea, vomiting, diarrhoea, and constipation were the most commonly reported adverse effects, particularly during dose escalation
Thus, in the early 1990s, pentadecapeptide BPC 157 [1,3,4,9,32,33,34,92] appeared as a late offshoot of the cytoprotectionorganoprotection concept of Robert and Szabo [32,33,34,35,36,37,38,39,40,41,42], for epithelial and endothelial protection
In a world of trending wellness fads and unregulated online shops, Meeting Point Health stands apart by treating peptide therapy as a precise medical science, not a quick fix
If the cap or seal is broken, discarding the vial is satisfactory to avoid infection
--- ## My Current Batch & Protocol I just mixed a new batch at 50mg/mL concentration: **Concentration:** 50mg/mL **Raw Powder:** 500mg **Bacteriostatic Water:** 10mL **Final Volume:** 10mL at 50mg/mL **Current dosing:** - 20mg daily (every morning, fasted) - Just restarted after a 2-week break at the same 20mg dose I stopped at - 0 ] Notice the distinct red color of the solution
